The U.S. Povidone market continued to strengthen during May 2026, following the bullish momentum established in April as elevated import costs, tight prompt availability, and resilient pharmaceutical demand supported higher CFR offers. Importers faced rising replacement costs for Povidone cargoes from China and Europe due to sustained freight expenses, controlled export allocations, and extended customs clearance timelines. Pharmaceutical and medical-device manufacturers remained the key demand drivers for Povidone, increasing procurement ahead of summer production cycles for antiseptic and healthcare formulations. Distributors also expanded safety-stock purchases after experiencing delayed replenishment schedules in April, further tightening spot availability across the U.S. market. Buyers increasingly prioritized supply security over aggressive negotiations, intensifying competition for limited Povidone cargoes. Supply conditions remained constrained amid disciplined pricing strategies from exporters and prolonged shipping lead times. Market participants now expect the Povidone market to maintain a firm near-term outlook, with prices projected to rise an additional 5–6% if freight and restocking pressures persist.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
